Incretins
CagriSema
Quick profile: two-component formulation, purity ≥99%, certificate of analysis per batch on request.
| Purity | ≥99% by HPLC |
|---|---|
| CAS number | See batch documentation |
| Molecular weight | See batch documentation |
| Molecular formula | See batch documentation |
| Material class | Two-component peptide blend |
| Appearance | White to off-white lyophilized powder |
| Available sizes | 5mg total · 10mg total · 20mg total |
| Documentation | Certificate of analysis on request |
CagriSema combines the amylin analogue cagrilintide with the GLP-1 analogue semaglutide, intended for controlled in-vitro research, comparative signalling studies and analytical compatibility assessment.
Both components carry a fatty-acid conjugation but differ in chain length and linker chemistry, so despite their similar general character they show distinct retention times on reversed-phase HPLC and can be resolved separately. Identity and purity are determined independently for each component, by MS and chromatography respectively.
A purity specification of ≥99% (HPLC) applies to both components; the batch certificate of analysis records these values per component and is available for the product on request.
Related products
| Catalog | CAS number | Molecular weight | Available sizes | ||
|---|---|---|---|---|---|
 | CagrilintideIncretins | 1415456-99-3 | 4409 g/mol (acetate) | 5mg · 10mg · 20mg | View details → |
 | RC10Incretins | — | — | 10mg total | View details → |
 | RetatrutideIncretins | 2381089-83-2 | 4731 g/mol | 10mg · 15mg · 20mg · 30mg · 40mg · 60mg | View details → |
 | RTT60Incretins | — | — | 60mg total | View details → |
 | SemaglutideIncretins | 910463-68-2 | 4113.58 g/mol | 5mg · 10mg · 15mg · 20mg · 50mg | View details → |